PONAXEM 1 g, powder for solution for injection or infusion 10 bottles
Active ingredients: Meropenem, Meropenem trihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection or infusion10 bottlesintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PONAXEM 1 g, poudre pour solution injectable ou pour perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre
- Marketing authorisation holder
- LABORATOIRES GERDA
- Reimbursement according to BDPM
- —
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans le cas suivant :<br><br>- Certaines infections broncho-pulmonaires chez le patient atteint de mucoviscidose ; JOURNAL OFFICIEL ; 20/05/09
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 10 Apr 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60489738CIP72790153CIP133400927901539Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉROPÉNEM TRIHYDRATÉpoudre | — | SA |
| MÉROPÉNEM ANHYDREpoudre | 1000 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.